SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-044951
Filing Date
2013-09-19
Accepted
2013-09-19 19:34:24
Documents
2
Period of Report
2013-09-19

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c598615_3x1.html 3  
1 MAIN DOCUMENT DESCRIPTION c598615_3x1.xml 3 5991
2 POWER OF ATTORNEY c598615_24.htm EX-24 5157
  Complete submission text file 0001209191-13-044951.txt   12689
Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Issuer) CIK: 0001385228 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O BIND THERAPEUTICS, INC. 325 VASSAR ST CAMBRIDGE MA 02139
Business Address
Farokhzad Omid (Reporting) CIK: 0001586852 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36072 | Film No.: 131106482